COGT
Cogent Biosciences, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -13.3% ·
aandelenstroom -1.4% ·
netto nieuwe posities -15.4%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 104 | +4 | 108.47M | $4.20B | +7 | −3 |
| Q1 2026 | 103 | +9 | 108.14M | $4.02B | +15 | −6 |
| Q4 2025 | 92 | +1 | 96.22M | $3.42B | +1 | — |
| Q3 2025 | 20 | +4 | 59.75M | $857.99M | +4 | — |
| Q2 2025 | 13 | -2 | 45.58M | $327.23M | — | −2 |
| Q1 2025 | 12 | -1 | 13.98M | $83.77M | — | −1 |
| Q4 2024 | 13 | 0 | 17.19M | $134.06M | +1 | −1 |
| Q3 2024 | 12 | +2 | 19.61M | $211.75M | +2 | — |
| Q2 2024 | 10 | — | 18.90M | $159.29M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 17.08M | — | $122.62M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 17.08M | — | $122.62M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 17.08M | — | $122.62M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 8.63M | — | $61.94M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 8.63M | — | $61.94M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 8.63M | — | $61.94M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 8.63M | — | $61.94M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 8.63M | — | $61.94M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 8.63M | — | $61.94M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 8.63M | — | $61.94M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 8.63M | — | $61.94M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 8.63M | — | $61.94M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 8.63M | — | $61.94M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passief) | 6.52M | — | $46.83M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 6.52M | — | $46.83M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 6.52M | — | $46.83M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 6.52M | — | $46.83M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 6.52M | — | $46.83M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 4.91M | -7.2% | $35.27M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passief) | 3.37M | -18.1% | $24.21M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passief) | 2.67M | +10.6% | $19.19M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Geode Capital Management ✦ (passief) | 2.67M | +10.6% | $19.19M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Millennium Management ✦ | 969.97K | +88.5% | $6.96M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 621.24K | +26.9% | $4.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 621.24K | +26.9% | $4.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Wellington Management ✦ | 297.36K | +15.1% | $2.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Wellington Management ✦ | 297.36K | +15.1% | $2.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Wellington Management ✦ | 297.36K | +15.1% | $2.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 273.54K | +25.8% | $1.96M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 273.54K | +25.8% | $1.96M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Fisher Asset Management ✦ | 110.91K | 0.0% | $796,319 | 0.0% | Held | 5 | SEC ↗ |
| 32 | T. Rowe Price ✦ | 73.15K | +34.5% | $526,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 45.08K | -72.0% | $323,682 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 45.08K | -72.0% | $323,682 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 45.08K | -72.0% | $323,682 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 45.08K | -72.0% | $323,682 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Renaissance Technologies | $1.53M | was 0.0% |
| Two Sigma Investments | $567,882 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 304 houders, 186.07M aandelen, $6.90B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.